메뉴 건너뛰기




Volumn 15, Issue 5, 2013, Pages

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis

Author keywords

[No Author keywords available]

Indexed keywords

BRODALUMAB; INTERLEUKIN 17 RECEPTOR; PLACEBO; ANTIRHEUMATIC AGENT; METHOTREXATE; MONOCLONAL ANTIBODY;

EID: 84886226230     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4347     Document Type: Article
Times cited : (95)

References (21)
  • 1
    • 84855172814 scopus 로고    scopus 로고
    • The pathogenesis of rheumatoid arthritis
    • 10.1056/NEJMra1004965, 22150039
    • McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011, 365:2205-2219. 10.1056/NEJMra1004965, 22150039.
    • (2011) N Engl J Med , vol.365 , pp. 2205-2219
    • McInnes, I.B.1    Schett, G.2
  • 2
    • 84859862757 scopus 로고    scopus 로고
    • Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road
    • Daikh DI, St Clair EW. Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road. Arthritis Care Res 2012, 64:648-651.
    • (2012) Arthritis Care Res , vol.64 , pp. 648-651
    • Daikh, D.I.1    St Clair, E.W.2
  • 4
    • 80053600391 scopus 로고    scopus 로고
    • Recent advances in the IL-17 cytokine family
    • 10.1016/j.coi.2011.07.006, 3190066, 21852080
    • Gaffen SL. Recent advances in the IL-17 cytokine family. Curr Opin Immunol 2011, 23:613-619. 10.1016/j.coi.2011.07.006, 3190066, 21852080.
    • (2011) Curr Opin Immunol , vol.23 , pp. 613-619
    • Gaffen, S.L.1
  • 5
    • 69349093225 scopus 로고    scopus 로고
    • Interleukin-17 and type 17 helper T cells
    • 10.1056/NEJMra0707449, 19710487
    • Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009, 361:888-898. 10.1056/NEJMra0707449, 19710487.
    • (2009) N Engl J Med , vol.361 , pp. 888-898
    • Miossec, P.1    Korn, T.2    Kuchroo, V.K.3
  • 6
    • 84866934694 scopus 로고    scopus 로고
    • Targeting IL-17 and TH17 cells in chronic inflammation
    • 10.1038/nrd3794, 23023676
    • Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012, 11:763-776. 10.1038/nrd3794, 23023676.
    • (2012) Nat Rev Drug Discov , vol.11 , pp. 763-776
    • Miossec, P.1    Kolls, J.K.2
  • 9
    • 21644479222 scopus 로고    scopus 로고
    • Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin
    • 10.1186/ar1733, 1175027, 15987480
    • Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005, 7:R784-R795. 10.1186/ar1733, 1175027, 15987480.
    • (2005) Arthritis Res Ther , vol.7
    • Raza, K.1    Falciani, F.2    Curnow, S.J.3    Ross, E.J.4    Lee, C.Y.5    Akbar, A.N.6    Lord, J.M.7    Gordon, C.8    Buckley, C.D.9    Salmon, M.10
  • 11
    • 40549138745 scopus 로고    scopus 로고
    • Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers
    • 10.1002/art.23291, 2675006, 18311821
    • Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008, 58:875-887. 10.1002/art.23291, 2675006, 18311821.
    • (2008) Arthritis Rheum , vol.58 , pp. 875-887
    • Nistala, K.1    Moncrieffe, H.2    Newton, K.R.3    Varsani, H.4    Hunter, P.5    Wedderburn, L.R.6
  • 12
    • 0031802932 scopus 로고    scopus 로고
    • Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines
    • Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998, 161:409-414.
    • (1998) J Immunol , vol.161 , pp. 409-414
    • Chabaud, M.1    Fossiez, F.2    Taupin, J.L.3    Miossec, P.4
  • 13
    • 77950535421 scopus 로고    scopus 로고
    • LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study
    • 10.1002/art.27334, 20131262
    • Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P, Sloan-Lancaster J. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 2010, 62:929-939. 10.1002/art.27334, 20131262.
    • (2010) Arthritis Rheum , vol.62 , pp. 929-939
    • Genovese, M.C.1    Van den Bosch, F.2    Roberson, S.A.3    Bojin, S.4    Biagini, I.M.5    Ryan, P.6    Sloan-Lancaster, J.7
  • 15
    • 0026629688 scopus 로고
    • The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
    • 10.1002/art.1780350502, 1575785
    • Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992, 35:498-502. 10.1002/art.1780350502, 1575785.
    • (1992) Arthritis Rheum , vol.35 , pp. 498-502
    • Hochberg, M.C.1    Chang, R.W.2    Dwosh, I.3    Lindsey, S.4    Pincus, T.5    Wolfe, F.6
  • 18
    • 84866391313 scopus 로고    scopus 로고
    • Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial
    • 10.1038/jid.2012.163, 22622425
    • Papp KA, Reid C, Foley P, Sinclair R, Salinger DH, Williams G, Dong H, Krueger JG, Russell CB, Martin DA. Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. J Invest Dermatol 2012, 132:2466-2469. 10.1038/jid.2012.163, 22622425.
    • (2012) J Invest Dermatol , vol.132 , pp. 2466-2469
    • Papp, K.A.1    Reid, C.2    Foley, P.3    Sinclair, R.4    Salinger, D.H.5    Williams, G.6    Dong, H.7    Krueger, J.G.8    Russell, C.B.9    Martin, D.A.10
  • 19
    • 84887412452 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, multiple-dose study to evaluate the safety, tolerability, and efficacy of brodalumab (AMG 827) in subjects with rheumatoid arthritis and an inadequate response to methotrexate [abstract 831]
    • doi:10.1002/art.38564
    • Pavelka K, Chon Y, Newmark R, Erondu N, Lin SL. A randomized, double-blind, placebo-controlled, multiple-dose study to evaluate the safety, tolerability, and efficacy of brodalumab (AMG 827) in subjects with rheumatoid arthritis and an inadequate response to methotrexate [abstract 831]. Arthritis Rheum 2012, 64:S362. doi:10.1002/art.38564.
    • (2012) Arthritis Rheum , vol.64
    • Pavelka, K.1    Chon, Y.2    Newmark, R.3    Erondu, N.4    Lin, S.L.5
  • 20
    • 84874552498 scopus 로고    scopus 로고
    • A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: naive to biologic therapy or inadequate responders to tumor necrosis factor α inhibitors [abstract]
    • Genovese MC, Greenwald MW, Cho CS, Berman A, Jin L, Cameron G, Wang L, Xie L, Braun D, Subhashis B, Warner L. A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: naive to biologic therapy or inadequate responders to tumor necrosis factor α inhibitors [abstract]. Arthritis Rheum 2011, 63:2591.
    • (2011) Arthritis Rheum , vol.63 , pp. 2591
    • Genovese, M.C.1    Greenwald, M.W.2    Cho, C.S.3    Berman, A.4    Jin, L.5    Cameron, G.6    Wang, L.7    Xie, L.8    Braun, D.9    Subhashis, B.10    Warner, L.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.